Consistent with our prior study [6], DPM activated NOX in KC, while its activation was significantly suppressed by ESR-Ex, as well as a specific pharmacological inhibitor of NOX, apocynin (Apo) (Figure 2A). The gene discussed is AOPEP; the disease is keratoconus.